The APOS System

Admin2 · Mar 8, 2022

Members do not see these Ads. Sign Up.
Just realized that we have a couple of disjointed threads on this:
AposTherapy Biomechanical Devices
The APOS system

NewsBot · Sep 30, 2014

Reduction of frontal-plane hip joint reaction force via medio-lateral foot center of pressure manipulation: A pilot study
Deborah Solomonow-Avnon, Alon Wolf, Amir Herman, Nimrod Rozen and Amir Haim
Journal of Orthopaedic Research Article first published online: 25 SEP 2014

Footwear-generated biomechanical manipulation of lower-limb joints has been shown to influence lower-limb biomechanics. Numerous studies report the influence of such interventions on the knee, however little is known about the influence of these interventions on the hip. The present study analyzed kinetic and kinematic changes about the hip of 12 healthy young males who underwent biomechanical manipulation utilizing the APOS biomechanical device (APOS–Medical and Sports Technologies Ltd., Herzliya, Israel) allowing controlled foot center of pressure manipulation. Subjects underwent gait testing in four para-sagittal device configurations: Medial, lateral, neutral, and regular shoes. In the medial configuration, subjects demonstrated no change in step width (i.e., distance between right and left foot center of pressure), however inter-malleolar distance significantly increased. Likewise with the medial setting, greater hip abduction was recorded, while hip adduction moment and joint reaction force decreased significantly. We speculate that subjects adopt a modified gait pattern aimed to maintain constant base of support. As a result, hip abductor muscle moment arm increases and adduction moment and joint reaction force decreases. To the best of our knowledge this is the first study to show this relationship. These results contribute to the understanding of lower-limb biomechanics and warrant further investigation
Click to expand...

Admin2 · Sep 30, 2014

Best foot forward: “AposTherapy – ‘con’ or convert?”

Admin2 · Sep 30, 2014

Advertising Standards Authority Adjudication

NewsBot · May 13, 2020

Effect of Biomechanical Footwear on Knee Pain in People With Knee Osteoarthritis
The BIOTOK Randomized Clinical Trial
Stephan Reichenbach et al
JAMA. 2020;323(18):1802-1812. doi:10.1001/jama.2020.3565

Key Points
Question Is an individualized biomechanical footwear therapy effective for reducing knee pain in people with knee osteoarthritis?

Findings In this randomized clinical trial that included 220 participants with knee pain due to knee osteoarthritis, treatment with an individualized biomechanical footwear therapy compared with control footwear resulted in a lower Western Ontario and McMaster Universities Osteoarthritis Index pain subscore (range, 0-10) after 24 weeks of follow-up (1.3 vs 2.6, respectively), a difference that was statistically significant.

Meaning Although use of biomechanical footwear compared with control footwear resulted in an improvement in knee pain at 24 weeks of follow-up that was statistically significant, the difference was of uncertain clinical importance, and further research is needed to assess long-term efficacy and safety.
Click to expand...

Importance Individually calibrated biomechanical footwear therapy may improve pain and physical function in people with symptomatic knee osteoarthritis, but the benefits of this therapy are unclear.

Objective To assess the effect of a biomechanical footwear therapy vs control footwear over 24 weeks of follow-up.

Design, Setting, and Participants Randomized clinical trial conducted at a Swiss university hospital. Participants (N = 220) with symptomatic, radiologically confirmed knee osteoarthritis were recruited between April 20, 2015, and January 10, 2017. The last participant visit occurred on August 15, 2017.

Interventions Participants were randomized to biomechanical footwear involving shoes with individually adjustable external convex pods attached to the outsole (n = 111) or to control footwear (n = 109) that had visible outsole pods that were not adjustable and did not create a convex walking surface.

Main Outcomes and Measures The primary outcome was knee pain at 24 weeks of follow-up assessed with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscore standardized to range from 0 (no symptoms) to 10 (extreme symptoms). The secondary outcomes included WOMAC physical function and stiffness subscores and the WOMAC global score, all ranging from 0 (no symptoms) to 10 (extreme symptoms) at 24 weeks of follow-up, and serious adverse events.

Results Among the 220 randomized participants (mean age, 65.2 years [SD, 9.3 years]; 104 women [47.3%]), 219 received the allocated treatment and 213 (96.8%) completed follow-up. At 24 weeks of follow-up, the mean standardized WOMAC pain subscore improved from 4.3 to 1.3 in the biomechanical footwear group and from 4.0 to 2.6 in the control footwear group (between-group difference in scores at 24 weeks of follow-up, −1.3 [95% CI, −1.8 to −0.9]; P < .001). The results were consistent for WOMAC physical function subscore (between-group difference, −1.1 [95% CI, −1.5 to −0.7]), WOMAC stiffness subscore (between-group difference, −1.4 [95% CI, −1.9 to −0.9]), and WOMAC global score (between-group difference, −1.2 [95% CI, −1.6 to −0.8]) at 24 weeks of follow-up. Three serious adverse events occurred in the biomechanical footwear group compared with 9 in the control footwear group (2.7% vs 8.3%, respectively); none were related to treatment.

Conclusions and Relevance Among participants with knee pain from osteoarthritis, use of biomechanical footwear compared with control footwear resulted in an improvement in pain at 24 weeks of follow-up that was statistically significant but of uncertain clinical importance. Further research would be needed to assess long-term efficacy and safety, as well as replication, before reaching conclusions about the clinical value of this device.
Click to expand...

The APOS System

Admin2 Administrator Staff Member

NewsBot The Admin that posts the news.

Admin2 Administrator Staff Member

Admin2 Administrator Staff Member

NewsBot The Admin that posts the news.

The APOS system

Kaposi's sarcoma on the foot

AposTherapy Biomechanical Devices

Apostherapy

Topical Medications for Treating Diabetic Foot Ulcers - A Systematic Review

Muscular Systems and Their Influence on Foot Arches

Lipid-Based Nanocarriers as Drug Delivery Systems in Diabetic Foot Ulcer

Share This Page

The APOS System

Admin2 Administrator Staff Member

NewsBot The Admin that posts the news.

Admin2 Administrator Staff Member

Admin2 Administrator Staff Member

NewsBot The Admin that posts the news.

The APOS system

Kaposi's sarcoma on the foot

AposTherapy Biomechanical Devices

Apostherapy

Topical Medications for Treating Diabetic Foot Ulcers - A Systematic Review

Muscular Systems and Their Influence on Foot Arches

Lipid-Based Nanocarriers as Drug Delivery Systems in Diabetic Foot Ulcer

Share This Page

Useful Searches